R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 3,125 shares at $7.61 ($23K) on 2022-10-07, disclosed to the SEC on 2022-10-11.
Scheduled sale ($23k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.61 | 841 | $6K | 28.2% |
| 2 | $7.13 | 2,284 | $16K | 71.8% |
| Total | $7.26 avg | 3,125 | $23K | 100% |
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |
| ADPT | SELL | 2022-04-08 | $11K | — | Filing → |